BIOLASE Inc
Change company Symbol lookup
Select an option...
BIOL BIOLASE Inc
GOEV Canoo Inc
CHE Chemed Corp
ASTA WorldFlix Inc
$NQDM15LMCADN Nasdaq Developed Markets Telecommuni
BFZ BlackRock California Municipal Income Trust
CAR Avis Budget Group Inc
GIS General Mills Inc
VLN Valens Semiconductor Ltd
CIF MFS? Intermediate High Income Fund
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Equipment & Supplies | Small Cap Blend
Company profile

BIOLASE, Inc. (BIOLASE) provides laser systems for the dental industry. The Company develops, manufactures, markets and sells laser systems for dental practitioners and their patients. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft-tissue) systems. Waterlase dental laser systems flagship consist of the Waterlase Express, Waterlase iPlus, and the Waterlase MD and MDX which, produces electromagnetic energy with specific absorption and tissue interaction characteristics specifically designed for dental procedures in cutting hard tissue, such as bone and teeth, and soft tissue, such as gums and skin, without the heat, vibration, bleeding, or pressure associated with traditional dental treatments. Its diode soft tissue laser systems consist of the Epic X, Epic Hygiene, Epic Pro, Epic 10 and iLase diode lasers that perform soft tissue, hygiene, cosmetic procedures, teeth whitening, and provide temporary pain relief.

Closing Price
$0.5905
Day's Change
-0.0201 (-3.29%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.612
Day's Low
0.5895
Volume
(Heavy Day)
Volume:
2,583,855

10-day average volume:
1,378,322
2,583,855

Ocugen Inc. Stock Outperforms Competitors Despite Losses On The Day

5:13 pm ET September 10, 2021 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Ocugen Inc. (OCGN) slid 2.85% to $7.15 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.77% to 4,458.58 and Dow Jones Industrial Average falling 0.78% to 34,607.72. Ocugen Inc. closed $11.62 short of its 52-week high ($18.77), which the company achieved on February 8th.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Adverum Biotechnologies Inc. (ADVM) fell 4.27% to $2.24, Ocular Therapeutix Inc. (OCUL) fell 3.38% to $10.87, and Kodiak Sciences Inc. (KOD) fell 1.10% to $96.39. Trading volume (4.1 M) remained 9.4 million below its 50-day average volume of 13.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 10, 2021.

-MarketWatch Automation

	

(END) Dow Jones Newswires

September 10, 2021 17:13 ET (21:13 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.